DK0699687T3 - Fremgangsmåde til oprensning af rekombinant humant serumalbumin - Google Patents

Fremgangsmåde til oprensning af rekombinant humant serumalbumin

Info

Publication number: DK0699687T3
Authority: DK; Denmark
Prior art keywords: serum albumin; human serum; recombinant human; purifying recombinant; purifying
Prior art date: 1994-08-31

Application number

DK95113620T

Other languages

English (en)

Inventor

Munehiro Noda

Akinori Sumi

Takao Ohmura

Kazumasa Yokoyama

Original Assignee

Mitsubishi Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-31

Filing date

1995-08-30

Publication date

2004-04-26

1995-08-30 Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp

2004-04-26 Application granted granted Critical

2004-04-26 Publication of DK0699687T3 publication Critical patent/DK0699687T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Engineering & Computer Science (AREA)
Analytical Chemistry (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

DK95113620T 1994-08-31 1995-08-30 Fremgangsmåde til oprensning af rekombinant humant serumalbumin DK0699687T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP20770494		1994-08-31

Publications (1)

Publication Number	Publication Date
DK0699687T3 true DK0699687T3 (da)	2004-04-26

Family

ID=16544190

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95113620T DK0699687T3 (da)	1994-08-31	1995-08-30	Fremgangsmåde til oprensning af rekombinant humant serumalbumin

Country Status (9)

Country	Link
US (2)	US5962649A (da)
EP (1)	EP0699687B1 (da)
KR (1)	KR100392021B1 (da)
CN (2)	CN1080301C (da)
CA (1)	CA2157219C (da)
DE (1)	DE69532492T2 (da)
DK (1)	DK0699687T3 (da)
ES (1)	ES2211889T3 (da)
TW (1)	TW363065B (da)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5728553A (en)	1992-09-23	1998-03-17	Delta Biotechnology Limited	High purity albumin and method of producing
ES2211889T3 (es) *	1994-08-31	2004-07-16	Mitsubishi Pharma Corporation	Procedimiento para la purificacion de albumina de suero recombinante.
AU4837996A (en) *	1996-02-29	1997-09-16	Delta Biotechnology Limited	High purity albumin production process
US6632648B1 (en)	1996-05-14	2003-10-14	Elan Drug Delivery Limited	Methods of terminal sterilization of fibrinogen
WO1998006822A1 (en) *	1996-08-08	1998-02-19	Yoshitomi Pharmaceutical Industries, Ltd.	Culture medium and use of the same
IL137649A (en) *	1998-02-18	2004-08-31	Genentech Inc	Method of adsorption chromatography
US6830756B2 (en) *	1998-11-06	2004-12-14	Neomend, Inc.	Systems, methods, and compositions for achieving closure of vascular puncture sites
US6899889B1 (en) *	1998-11-06	2005-05-31	Neomend, Inc.	Biocompatible material composition adaptable to diverse therapeutic indications
US7351249B2 (en) *	1998-11-06	2008-04-01	Neomend, Inc.	Systems, methods, and compositions for achieving closure of suture sites
US7279001B2 (en) *	1998-11-06	2007-10-09	Neomend, Inc.	Systems, methods, and compositions for achieving closure of vascular puncture sites
GB9902000D0 (en)	1999-01-30	1999-03-17	Delta Biotechnology Ltd	Process
WO2001085928A1 (fr) *	2000-05-10	2001-11-15	Mitsubishi Pharma Corporation	Procede de preparation de vecteur de virus
US6787636B1 (en) *	2000-07-14	2004-09-07	New Century Pharmaceuticals, Inc.	Modified serum albumin with reduced affinity for nickel and copper
EP1175931A1 (en) *	2000-07-25	2002-01-30	Computer Cell Culture Center S.A.	Integration of high cell density bioreactor operation with ultra fast on-line downstream processing
DE50204952D1 (de)	2001-02-01	2005-12-22	Roche Diagnostics Gmbh	Verfahren zur herstellung von rekombinantem trypsin
JP2002265383A (ja) *	2001-03-14	2002-09-18	Mitsubishi Pharma Corp	インターフェロンα注射用液状製剤
PT1412384E (pt)	2001-06-28	2008-03-28	Novo Nordisk As	Formulação estável de glp-1 modificado
ITBO20010426A1 (it)	2001-07-06	2003-01-06	Alfa Wassermann Spa	Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
KR20030007186A (ko) *	2001-07-17	2003-01-23	미쯔이카가쿠 가부시기가이샤	광 양이온성 경화가능 수지 조성물 및 그 용도
WO2003072123A1 (fr) *	2002-02-28	2003-09-04	Nipro Corporation	Preparations d'albumine stabilisees
SE526227C2 (sv)	2002-05-15	2005-08-02	North China Pharmaceutical Group	Metod för rening av rekombinant humant serumalbumin
AU2003281982A1 (en) *	2002-11-26	2004-06-18	Novo Nordisk A/S	Process for purifying a fermentation-derived product
WO2004080575A1 (en) *	2003-03-12	2004-09-23	Fresenius Kabi Deutschland Gmbh	Use of recombinant albumin in dialysis after liver failure
EP1633391B1 (en)	2003-06-03	2011-10-19	Novo Nordisk A/S	Stabilized pharmaceutical peptide compositions
KR101308912B1 (ko)	2003-06-03	2013-09-23	노보 노르디스크 에이/에스	안정화된 약학적 펩티드 조성물
ES2727854T5 (en)	2003-11-20	2025-03-24	Novo Nordisk As	Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
JP2005245269A (ja) *	2004-03-03	2005-09-15	Nipro Corp	血清アルブミン多量体を含む遺伝子組換え型蛋白質
EP2230257A1 (en) *	2004-04-23	2010-09-22	ConjuChem Biotechnologies Inc.	Method for the purification of albumin conjugates
AU2005252296B2 (en)	2004-06-07	2009-08-20	Evolve Biologics Inc.	Isolation of plasma or serum proteins
CN100374560C (zh) *	2004-08-27	2008-03-12	富岩	高效表达人血清白蛋白酵母菌株的构建及发酵纯化工艺
PL1789434T3 (pl)	2004-08-31	2014-07-31	Novo Nordisk As	Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
ES2458991T3 (es)	2004-11-12	2014-05-07	Novo Nordisk A/S	Formulaciones estables de péptidos insulinotrópicos
CN1854306B (zh) *	2005-04-29	2011-07-27	华北制药集团新药研究开发有限责任公司	发酵生产重组人血清白蛋白hsa的方法
IL169230A (en)	2005-06-16	2012-03-29	Plasan Sasa Agricultural Cooperative Soc Ltd	Ballistic armor
WO2007063129A2 (en) *	2005-12-02	2007-06-07	Novozymes A/S	Insolation of peptides , polypeptides and proteins
JP4935242B2 (ja) *	2006-08-24	2012-05-23	ニプロ株式会社	脂肪酸を含有するｓ−ニトロソタンパク質とその製法
US20100267933A1 (en)	2006-12-21	2010-10-21	Moya Wilson	Purification of proteins
US8569464B2 (en)	2006-12-21	2013-10-29	Emd Millipore Corporation	Purification of proteins
AU2008207207B2 (en) *	2007-01-15	2012-10-18	Upfront Chromatography A/S	Production of biofuel and protein from a raw material
EP2370561B1 (en)	2008-12-16	2019-08-07	EMD Millipore Corporation	Stirred tank reactor and method
SG173469A1 (en)	2009-02-20	2011-09-29	Ventria Bioscience	Cell culture media containing combinations of proteins
CN102190722B (zh) *	2010-03-16	2014-03-26	上海欣瑞特生物医药技术有限公司	一种纯化重组人血白蛋白的方法
KR101726707B1 (ko)	2010-05-17	2017-04-13	이엠디 밀리포어 코포레이션	생체분자 정제용 자극 반응성 중합체
CN102532254B (zh) *	2010-12-24	2015-06-24	武汉禾元生物科技股份有限公司	一种从水稻种子中分离纯化重组人血清白蛋白的方法
US20140235474A1 (en)	2011-06-24	2014-08-21	Sequenom, Inc.	Methods and processes for non invasive assessment of a genetic variation
US10424394B2 (en)	2011-10-06	2019-09-24	Sequenom, Inc.	Methods and processes for non-invasive assessment of genetic variations
US9984198B2 (en)	2011-10-06	2018-05-29	Sequenom, Inc.	Reducing sequence read count error in assessment of complex genetic variations
US10196681B2 (en)	2011-10-06	2019-02-05	Sequenom, Inc.	Methods and processes for non-invasive assessment of genetic variations
US20140242588A1 (en)	2011-10-06	2014-08-28	Sequenom, Inc	Methods and processes for non-invasive assessment of genetic variations
US9367663B2 (en)	2011-10-06	2016-06-14	Sequenom, Inc.	Methods and processes for non-invasive assessment of genetic variations
HUE059847T2 (hu)	2012-01-20	2023-01-28	Sequenom Inc	Kísérleti körülményeket fakturáló diagnosztikai folyamatok
US9920361B2 (en)	2012-05-21	2018-03-20	Sequenom, Inc.	Methods and compositions for analyzing nucleic acid
US10504613B2 (en)	2012-12-20	2019-12-10	Sequenom, Inc.	Methods and processes for non-invasive assessment of genetic variations
US10482994B2 (en)	2012-10-04	2019-11-19	Sequenom, Inc.	Methods and processes for non-invasive assessment of genetic variations
US20130309666A1 (en)	2013-01-25	2013-11-21	Sequenom, Inc.	Methods and processes for non-invasive assessment of genetic variations
US10930368B2 (en)	2013-04-03	2021-02-23	Sequenom, Inc.	Methods and processes for non-invasive assessment of genetic variations
CA3189752A1 (en)	2013-05-24	2014-11-27	Sequenom, Inc.	Methods and processes for non-invasive assessment of genetic variations
LT3011051T (lt)	2013-06-21	2019-05-10	Sequenom, Inc.	Genetinių variacijų neinvazinis vertinimo būdas
KR102700888B1 (ko)	2013-10-04	2024-08-29	시쿼넘, 인코포레이티드	유전적 변이의 비침습 평가를 위한 방법 및 프로세스
CN111863131A (zh)	2013-10-07	2020-10-30	塞昆纳姆股份有限公司	用于非侵入性评估染色体改变的方法和过程
US11783911B2 (en)	2014-07-30	2023-10-10	Sequenom, Inc	Methods and processes for non-invasive assessment of genetic variations
WO2016108211A1 (en)	2015-01-01	2016-07-07	Navya Biologicals Pvt Ltd	Novel method for efficient purification of human serum albumin
US11200963B2 (en)	2016-07-27	2021-12-14	Sequenom, Inc.	Genetic copy number alteration classifications
WO2018140521A1 (en)	2017-01-24	2018-08-02	Sequenom, Inc.	Methods and processes for assessment of genetic variations
BR112020002804A2 (pt)	2017-08-24	2020-07-28	Novo Nordisk A/S	composição farmacêutica líquida, e, kit
TWI878456B (zh)	2020-02-18	2025-04-01	丹麥商諾佛儂迪克股份有限公司	Glp-1組成物及其用途
US12161777B2 (en)	2020-07-02	2024-12-10	Davol Inc.	Flowable hemostatic suspension
US11739166B2 (en)	2020-07-02	2023-08-29	Davol Inc.	Reactive polysaccharide-based hemostatic agent
CN114885608A (zh)	2020-12-08	2022-08-09	通化安睿特生物制药股份有限公司	纯化重组蛋白的方法
MX2023007767A (es)	2020-12-28	2023-07-07	Davol Inc	Materiales hemostaticos secos en polvo reactivos que comprenden una proteina y un agente de entrelazado a base de polietilenglicol modificado multifuncional.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR570916A (da)	1923-09-20	1924-05-09
US4228154A (en) *	1979-02-26	1980-10-14	Armour Pharmaceutical Company	Purification of plasma albumin by ion exchange chromatography
KR830002718A (ko)	1980-04-22	1983-05-30	가와무라 요시부미	피라졸 유도체의 제조법
US4665192A (en) *	1984-03-19	1987-05-12	The Rockefeller University	2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
FR2649991B2 (fr) *	1988-08-05	1994-03-04	Rhone Poulenc Sante	Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
JPH0671434B2 (ja) *	1989-09-18	1994-09-14	株式会社ミドリ十字	ヒト血清アルブミンの製造方法
JPH06501033A (ja) *	1991-07-12	1994-01-27	ギスト　ブロカデス　ナムローゼ　フェンノートシャップ	血清アルブミンの精製方法
JPH07102147B2 (ja) *	1992-03-16	1995-11-08	株式会社ミドリ十字	ヒト血清アルブミンの着色抑制方法
US5521287A (en) *	1992-05-20	1996-05-28	The Green Cross Corporation	Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) *	1992-05-20	1995-08-08	The Green Cross Corporation	Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
ES2211889T3 (es) *	1994-08-31	2004-07-16	Mitsubishi Pharma Corporation	Procedimiento para la purificacion de albumina de suero recombinante.

1995
- 1995-08-30 ES ES95113620T patent/ES2211889T3/es not_active Expired - Lifetime
- 1995-08-30 DK DK95113620T patent/DK0699687T3/da active
- 1995-08-30 CA CA2157219A patent/CA2157219C/en not_active Expired - Lifetime
- 1995-08-30 EP EP95113620A patent/EP0699687B1/en not_active Expired - Lifetime
- 1995-08-30 DE DE69532492T patent/DE69532492T2/de not_active Expired - Lifetime
- 1995-08-31 KR KR1019950027882A patent/KR100392021B1/ko not_active Expired - Lifetime
- 1995-08-31 CN CN95117159A patent/CN1080301C/zh not_active Expired - Lifetime
- 1995-08-31 US US08/522,089 patent/US5962649A/en not_active Expired - Lifetime
- 1995-09-11 TW TW084109447A patent/TW363065B/zh not_active IP Right Cessation
1999
- 1999-05-24 US US09/317,214 patent/US6617133B1/en not_active Expired - Lifetime
2001
- 2001-07-19 CN CN01123056A patent/CN1364643A/zh active Pending

Also Published As

Publication number	Publication date
CN1127299A (zh)	1996-07-24
ES2211889T3 (es)	2004-07-16
EP0699687B1 (en)	2004-01-28
KR100392021B1 (ko)	2003-11-01
US6617133B1 (en)	2003-09-09
TW363065B (en)	1999-07-01
KR960007612A (ko)	1996-03-22
EP0699687A2 (en)	1996-03-06
CA2157219C (en)	2010-10-05
DE69532492D1 (de)	2004-03-04
EP0699687A3 (en)	1996-12-18
CN1080301C (zh)	2002-03-06
DE69532492T2 (de)	2004-12-02
CN1364643A (zh)	2002-08-21
CA2157219A1 (en)	1996-03-01
US5962649A (en)	1999-10-05

Publication	Publication Date	Title
DK0699687T3 (da)	2004-04-26	Fremgangsmåde til oprensning af rekombinant humant serumalbumin
DK0570916T3 (da)	2002-05-13	Fremgangsmåde til rensning af humant rekombinant serumalbumin
DK1036179T4 (da)	2014-03-31	Fremgangsmåde til fremstilling af polypeptider med egnet glycosilering
FI965032L (fi)	1996-12-16	Interleukiini-5-spesifisiä yhdistelmä-vasta-aineita
DE69515391D1 (de)	2000-04-13	Narkosesystem
DK0420007T3 (da)	1994-02-21	Fremgangsmåde til rensning af human serumalbumin
FI944412L (fi)	1994-09-23	Proteiinin puhdistus
FI965225L (fi)	1997-02-26	Uusia peptidejä
FI961350A7 (fi)	1996-03-25	Hapteenimerkityt peptidit
DK0911416T3 (da)	2006-08-14	Fremgangsmåde til fremstilling af protein
FI972030A0 (fi)	1997-05-13	Puhdistettuja papillomavirusproteiineja
ATE480626T1 (de)	2010-09-15	Neue streptogramine
DK0656419T3 (da)	2002-09-30	Fremgangsmåde til højrensning af humant serumalbumin
NO980566D0 (no)	1998-02-10	Allergen-XCD32 fusjonsproteiner
DK0504823T3 (da)	1997-06-23	Fremgangsmåde til fremstilling af human serumalbumin
FI970168A0 (fi)	1997-01-15	Peptidejä
FI970205A0 (fi)	1997-01-17	Kaksoishybridijärjestelmä
DK0591605T3 (da)	2001-01-29	Fremgangsmåde til undertrykkelse af farvning af humant serumalbumin
FI964363L (fi)	1996-12-23	Peptidejä
DK0655503T3 (da)	2002-11-11	Fremgangsmåde til fremstilling af humant serumalbumin
DK0736605T3 (da)	2003-04-22	Fremgangsmåde til fremstilling af proteiner
DK0658569T3 (da)	2005-02-07	Fremgangsmåde til affarvning af humant serumalbumin
DK53792D0 (da)	1992-04-24	Fremgangsmaade til fremstilling af proteiner
DK13087A (da)	1987-07-14	Gensekvens til fremstilling af human serumalbumin i bacillus
DK281590A (da)	1991-05-29	Fremgangsmaade til regenereringsbehandling af overvejende lerbundet stoeberigammelsand